129 related articles for article (PubMed ID: 5327103)
1. Hepatolenticular degeneration: the comparative effectiveness of d-penicillamine, potassium sulfide, and diethylditbiocarbamate as decoppering agents.
Hsia YE; Combs JT; Hook L; Brandt IK
J Pediatr; 1966 Jun; 68(6):921-6. PubMed ID: 5327103
[No Abstract] [Full Text] [Related]
2. 50 Years Ago in TheJournal ofPediatrics: Hepatolenticular Degeneration: The Comparative Effectiveness of D-Penicillamine, Potassium Sulfide, and Diethyldithiocarbamate as Decoppering Agents.
Hafberg ET
J Pediatr; 2016 Jun; 173():55. PubMed ID: 27234281
[No Abstract] [Full Text] [Related]
3. COPPER BALANCE STUDIES IN WILSON'S DISEASE (HEPATOLENTICULAR DEGENERATION). OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBO-RESIN AND POTASSIUM SULFIDE.
GOLDSTEIN NP; RANDALL RV; GROSS JB; MCGUCKIN WF
Trans Am Neurol Assoc; 1963; 88():221-2. PubMed ID: 14272232
[No Abstract] [Full Text] [Related]
4. [Studies of the hepatolenticular degeneration and results of its continuous therapy].
Brailski C; Kolarski V; Krastev I
Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):35-42. PubMed ID: 5501424
[No Abstract] [Full Text] [Related]
5. COPPER BALANCE STUDIES IN WILSON'S DISEASE; OBSERVATIONS ON THE EFFECT OF PENICILLAMINE, CARBACRYLAMINE RESINS, AND POTASSIUM SULFIDE.
GOLDSTEIN NP; RANDALL RV; GROSS JB; MCGUCKIN WF
Arch Neurol; 1965 May; 12():456-62. PubMed ID: 14288982
[No Abstract] [Full Text] [Related]
6. Treatment of hepatolenticular degeneration. (Wilson's disease).
Spellberg MA
Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
[No Abstract] [Full Text] [Related]
7. Effect of penicillamine on serum iron.
Walshe JM; Patston V
Arch Dis Child; 1965 Dec; 40(214):651-3. PubMed ID: 5844954
[No Abstract] [Full Text] [Related]
8. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
9. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
Indaco A; Pellegrino L; Campanella G
Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
[No Abstract] [Full Text] [Related]
10. [Use of penicillamine in Wilson-Konovalov disease].
Vakharlovskiĭ VG; Nikitina LI; Bondarchuk AN
Klin Med (Mosk); 1980 Jan; 58(1):56-60. PubMed ID: 7366142
[No Abstract] [Full Text] [Related]
11. [Hepatolenticular degeneration. Clinical course in 2 siblings during penicillamine therapy].
Højer-Pedersen E
Ugeskr Laeger; 1979 Sep; 141(38):2610-1. PubMed ID: 483457
[No Abstract] [Full Text] [Related]
12. Some problems of the penicillamine action in hepatolenticular degeneration.
Chromy K; Heyrovsky A
Metabolism; 1966 Jun; 15(6):529-36. PubMed ID: 5933915
[No Abstract] [Full Text] [Related]
13. [Hepatolenticular degeneration treated by Cuprenil Polfa (d-penicillamine)].
Hasik J; Kozal H
Pol Tyg Lek; 1975 Aug 4-11; 30(31-32):1329-30. PubMed ID: 1161576
[No Abstract] [Full Text] [Related]
14. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
Lange J; Brandt G
Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
[No Abstract] [Full Text] [Related]
15. [Experiences with penicillamine in Wilson's disease].
Lössner J; Bachmann H; Eichner B
Psychiatr Neurol Med Psychol Beih; 1975; 20-21():48-53. PubMed ID: 829635
[TBL] [Abstract][Full Text] [Related]
16. Metabolic studies in Wilson's disease. Evaluation of efficacy of chelation therapy in respect to copper balance.
Strickland GT; Blackwell RQ; Watten RH
Am J Med; 1971 Jul; 51(1):31-40. PubMed ID: 5570318
[No Abstract] [Full Text] [Related]
17. Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration).
Berry WR; Aronson AE; Darley FL; Goldstein NP
Mayo Clin Proc; 1974 Jun; 49(6):405-8. PubMed ID: 4835812
[No Abstract] [Full Text] [Related]
18. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
Germinario L; Campanella G; D'Addabbo A
Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
[No Abstract] [Full Text] [Related]
19. [Penicillamine treatment of Wilson's disease].
Falkmer S; Samuelson G; Sjölin S
Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
[No Abstract] [Full Text] [Related]
20. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
Walshe JM
Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
[No Abstract] [Full Text] [Related]
[Next] [New Search]
